Atlas Trials

ELUCIDATE: Enabling Lung Cancer Identification Using Folate Receptor Targeting

Clinical trial NCT04241315 · COMPLETED

Trial details

NCT number
NCT04241315
Sponsor
On Target Laboratories, LLC
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Lung NeoplasmsLung Cancer
Start date
2020-03-26
Primary completion
2021-10-07
Enrollment
112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.